Cancer Immunology Research

Journal Title：Cancer Immunology Research

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

Cancer Immunology Research 发表优秀的原创文章，报道癌症免疫学的重大进展，涵盖从宿主-肿瘤相互作用的基础研究到模型系统中的发育治疗、患者的早期转化研究和后期临床试验的学科。该杂志向癌症研究界传播免疫学知识，促进跨学科工作，从而更深入地了解宿主与肿瘤的关系、更有效的癌症治疗方法并改善临床结果。

论文经过严格审查，感兴趣的具体主题包括内源性抗肿瘤免疫、促肿瘤炎症、癌症抗原、疫苗、抗体、细胞疗法、细胞因子、免疫调节、免疫抑制、癌症治疗的免疫调节作用、新兴技术、和临床研究。该杂志的特色包括“免疫学大师”（由领先的免疫学家撰写的引物）和“处于十字路口的癌症免疫学”——突出免疫学与癌症研究和相关学科其他领域的交叉点的观点。

Cancer Immunology Research创刊于2013年，由AMER ASSOC CANCER RESEARCH出版商出版，收稿方向涵盖ONCOLOGY - IMMUNOLOGY全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。影响因子指数8.728，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。